| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| DABI | DABI Impurity 2 | VL42100001 | View CAS 42288-26-6 |
DABI Impurities
| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| DABI | DABI Impurity 2 | VL42100001 | View CAS 42288-26-6 |
[rfq_list]
| Catalogue No. | VL42100001 |
| CAS No. | 42288-26-6 |
| Molecular Formula | C9H8N2O2 |
| Molecular Weight | 176.18 |
| Parent drug | DABI |
| IUPAC Name | N-(4-Cyanophenyl)glycine |
| Synonyms | N-(4-Cyanophenyl)glycine |
| References | “Current Scenario of Poly (2, 5-Benzimidazole) (ABPBI) as Prospective PEM for Application in HT-PEMFC.” Polymer Reviews, 2020, http://www.tandfonline.com/doi/abs/10.1080/15583724.2019.1663211.? |
| Status | In-stock |
| ListName | DABI Impurity 2 |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
